European Lithium Deal Implies 45% Upside, But ASX Probe and Permitting Delays Cloud the Picture

European Lithium's merger with Critical Metals offers a 45% premium, but ASX suspension, governance issues, and Wolfsberg delays fuel doubt over Tanbreez rare earths deal.

The binding merger agreement between European Lithium and Nasdaq-listed Critical Metals Corp., signed on 18 May 2026, offers shareholders a headline premium that looks almost too good to be true. Under the all-stock transaction, each European Lithium share will be exchanged for 0.035 Critical Metals shares, implying a value of A$0.58 per share. That represents a 45% premium over the most recent traded price of A$0.40, and a chunky 137% above the last undisturbed close. Yet the stock has remained suspended on the ASX since the deal was announced — and the wide gap between the implied value and the suspended price tells a story of deep market skepticism.

Investors are weighing a complex mosaic of opportunity and risk. The strategic centrepiece is Tanbreez, a rare earths deposit in Greenland that ranks among the world’s largest known heavy rare earth sources, containing critical minerals such as dysprosium and terbium. On 21 May, Critical Metals signed a 15-year offtake agreement with REalloys Inc. covering 15% of Tanbreez’s annual concentrate production, with preferential rights and first refusal on additional volumes. That formalises a letter of intent from October 2025 and brings the total offtake coverage to around 75% of expected output. Phase 1 capacity is set at 15,000 tonnes of concentrate per year, with commercial production of dysprosium, terbium and neodymium scheduled for January 2027.

The project’s geopolitical importance is growing. From 2027, new US procurement rules will effectively ban rare earths from China, positioning Tanbreez as a non-China supplier of choice. The resource stands at roughly 45 million tonnes with a heavy rare earth content of 27%. A pilot plant in Qaqortoq is already complete, and a 150-tonne bulk sample is planned for June — though a local operating permit is still pending and could delay the sample extraction.

But not all of European Lithium’s assets are firing on all cylinders. Its Austrian Wolfsberg lithium project suffered a setback in November 2025 when the Federal Administrative Court overturned a simplified environmental assessment and ordered the Carinthian state government to re-evaluate. The final investment decision has now been pushed back to at least the end of 2026, while the mining licence runs only until early 2028. BMW’s offtake contract is not affected by the delay, but the timeline adds another layer of uncertainty to the merger’s operational rationale.

Governance concerns are also weighing on the deal. Tony Sage serves as both executive chairman of European Lithium and CEO of Critical Metals, a conflict that has already prompted an independent committee to protect minority shareholders. Meanwhile, the ASX is formally investigating whether European Lithium breached its continuous disclosure obligations. The company argues that the negotiations only became material once a non-binding letter of intent was signed in late April, but the probe adds regulatory risk to an already thick timetable.

The merger is structured as an Australian scheme of arrangement, requiring both a majority of voting shareholders by headcount and at least 75% approval by value. The scheme booklet is expected to be dispatched in July or August, with shareholder meetings in August or September, followed by court and regulatory approvals. That timeline means a final decision is unlikely before autumn.

A key condition has already been cleared: Critical Metals raised A$45 million by selling 2.5 million of its own shares, boosting its cash reserves to around A$356 million. That comfortably exceeds the contractual threshold of A$330 million. European Lithium itself brings roughly A$306 million in cash into the combined entity and is conducting an on-market share buyback of up to 10% of issued capital, capped at A$12.6 million, with purchased shares cancelled.

The deal may look compelling on paper — a 45% premium, a Greenland rare earths prize, and a well-capitalised partner. But between the ASX investigation, the Wolfsberg delay, the permitting risk at Tanbreez, and the governance questions, the market is pricing in more than a few stumbling blocks. Shareholders will have their say in August or September, and until then the stock remains suspended — a reminder that a binding agreement is not the same as a done deal.